Nora Pashayan (@norapashayan) 's Twitter Profile
Nora Pashayan

@norapashayan

Public health doctor | Prof @Cambridge_Uni| Hon Prof @UCL | Research in cancer screening | views mine / RTs not endorsement

ID: 571144414

linkhttps://iris.ucl.ac.uk/research/personal?upi=NPASH45 calendar_today04-05-2012 20:53:01

401 Tweet

367 Followers

401 Following

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

πŸ“’ Job opportunity Come join me as a postdoc researcher Cambridge University working on stochastic modelling for cancer screening. Application closing on 13th August. To apply jobs.cam.ac.uk/job/41966/

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

Artsakh Peace Festival, virtual platform of classical musicians united to open the Road of Life to Artsakh m.youtube.com/@ArtsakhPeaceF…

Chris Jackson (@cjackstats) 's Twitter Profile Photo

If you like multistate / survival modelling you may be interested in this position jobs.cam.ac.uk/job/41966/ collaborating with some good people in a neighbouring department.

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

12 recommendations to improve representation of minoritised groups in research in cancer #earlydetection nature.com/articles/s4141… by the #ACED funded REPRESENT group

Antonis Antoniou (@antonis02) 's Twitter Profile Photo

We’re looking for a (senior) research associate to assist building the Science and Innovation at Cancer Research UK Cancer Data Driven Detection #CD3 initiative. An expert in health data science? Check out this exciting & flexible opportunity Cambridge University jobs.cam.ac.uk/job/43687/ Closes 8 Nov #epitwitter

Dr Chiara Herzog (@chiara_herzog) 's Twitter Profile Photo

πŸ”¬New findings on breast cancer risk prediction: our study in npj Precision Oncology reveals the power of epigenetics in understanding risk, focusing genetic X nonheritable factors captured on the epigenome in the "right" surrogate sample 🧬 πŸ‘‰ doi.org/10.1038/s41698…

Prostate Cancer UK (@prostateuk) 's Twitter Profile Photo

Introducing the TRANSFORM trial. A Β£42 million research programme, led and developed by us and backed by Β£16 million of government funding. It's the biggest and most ambitious prostate cancer trial in 20 years. πŸ‘‰ Find out more: bit.ly/3SInU51

Introducing the TRANSFORM trial.  

A Β£42 million research programme, led and developed by us and backed by Β£16 million of government funding.  

It's the biggest and most ambitious prostate cancer trial in 20 years. 

πŸ‘‰ Find out more: bit.ly/3SInU51
Paul Pharoah (R soul) πŸ‡ͺπŸ‡ΊπŸ‡΅πŸ‡¬πŸ‡ΏπŸ‡¦πŸ‡¬πŸ‡§ (@paulpharoah) 's Twitter Profile Photo

1/n An all new version of PREDICT breast is now live at breast.v3.predict.cam Thanks to Alexandra Freeman, Mehdi Hajjam, @ProfWishart, David Spiegelhalter and Isabelle Grootes. V2.2 still available at breast.predict.cam. Major changes are....

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

We’re looking for a research associate to develop simulation models for evaluating cancer early detection. An expert in stochastic modelling? Check out this exciting opportunity Cambridge University jobs.cam.ac.uk/job/47297/

Siddhartha Kar (@siddhartha_kar) 's Twitter Profile Photo

πŸ“’ In print this week on the role of polygenic risk scores in cancer screening πŸ‘‡ thelancet.com/journals/lance… Co-authored with rising ⭐ clinical academic Sarah Perrott, who recently completed the research rotation of her specialised foundation programme with us at Early Cancer Institute, University of Cambridge

πŸ“’ In print this week on the role of polygenic risk scores in cancer screening πŸ‘‡

thelancet.com/journals/lance…

Co-authored with rising ⭐ clinical academic <a href="/perrott_sarah/">Sarah Perrott</a>, who recently completed the research rotation of her specialised foundation programme with us at <a href="/EarlyCancerCam/">Early Cancer Institute, University of Cambridge</a>
Antonis Antoniou (@antonis02) 's Twitter Profile Photo

Latest publication from the group on evaluating the performance of CanRisk / BOADICEA canrisk.org in predicting ovarian cancer risk Paper: nature.com/articles/s4141… Thread by Xin πŸ‘‡

Paul Pharoah (R soul) πŸ‡ͺπŸ‡ΊπŸ‡΅πŸ‡¬πŸ‡ΏπŸ‡¦πŸ‡¬πŸ‡§ (@paulpharoah) 's Twitter Profile Photo

1/2 We have previously developed a method for generating a poygenic model using summary statistics - called S4. We have compared S4 with LDPred2 for 12 different phenotypes as well as developing a composite S4+LDPred2 method. link.springer.com/10.1186/s12864…

Nora Pashayan (@norapashayan) 's Twitter Profile Photo

Applications for the ACED 4-Year PhD Studentship at are now open!! Deadline Monday 4thΒ November 2024. Further details earlycancer.cam.ac.uk/aced-phd-stude…

Early Cancer Institute, University of Cambridge (@earlycancercam) 's Twitter Profile Photo

πŸ™ŒHands up if you're a highly motivated and talented scientist looking for a unique, multi-disciplinary training programme in cancer early detection?πŸ™Œ Apply for the ACED 4-year #PhD Studentship by 4th Nov 2024 and you could be joining our amazing team! earlycancer.cam.ac.uk/aced-phd-stude…

πŸ™ŒHands up if you're a highly motivated and talented scientist looking for a unique, multi-disciplinary training programme in cancer early detection?πŸ™Œ
Apply for the ACED 4-year #PhD Studentship by 4th Nov 2024 and you could be joining our amazing team!
earlycancer.cam.ac.uk/aced-phd-stude…
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM nejm.org/doi/full/10.10… Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer (BARCODE1) out on NEJM 

nejm.org/doi/full/10.10…

Study evaluated a targeted #ProstateCancer screening approach using polygenic risk scores derived from 130 known genetic variants, identifying men aged 55–69 in